Regensburg Center for Biochemistry, University of Regensburg, D-93053 Regensburg, Germany.
Biol Chem. 2023 Jul 17;404(11-12):1003-1023. doi: 10.1515/hsz-2023-0214. Print 2023 Oct 26.
The ribosomal RNA precursor (pre-rRNA) comprises three of the four ribosomal RNAs and is synthesized by RNA polymerase (Pol) I. Here, we describe the mechanisms of Pol I transcription in human cells with a focus on recent insights gained from structure-function analyses. The comparison of Pol I-specific structural and functional features with those of other Pols and with the excessively studied yeast system distinguishes organism-specific from general traits. We explain the organization of the genomic rDNA loci in human cells, describe the Pol I transcription cycle regarding structural changes in the enzyme and the roles of human Pol I subunits, and depict human rDNA transcription factors and their function on a mechanistic level. We disentangle information gained by direct investigation from what had apparently been deduced from studies of the yeast enzymes. Finally, we provide information about how Pol I mutations may contribute to developmental diseases, and why Pol I is a target for new cancer treatment strategies, since increased rRNA synthesis was correlated with rapidly expanding cell populations.
核糖体 RNA 前体 (pre-rRNA) 由四个核糖体 RNA 中的三个组成,由 RNA 聚合酶 (Pol) I 合成。在这里,我们描述了人细胞中 Pol I 转录的机制,重点介绍了近年来从结构功能分析中获得的新见解。将 Pol I 特有的结构和功能特征与其他 Pol 以及过度研究的酵母系统进行比较,区分了特定于生物体的特征和普遍特征。我们解释了人细胞中基因组 rDNA 基因座的组织,描述了 Pol I 转录循环,包括酶的结构变化以及人 Pol I 亚基的作用,并在机制水平上描述了人类 rDNA 转录因子及其功能。我们将直接研究获得的信息与从对酵母酶的研究中显然推断出的信息区分开来。最后,我们提供了有关 Pol I 突变如何导致发育性疾病的信息,以及为什么 Pol I 是新癌症治疗策略的目标,因为增加 rRNA 合成与快速扩张的细胞群体相关。